CancerCareE | International Oncology Access Platform | CAR-T & Advanced Cancer Treatments
Your Trusted Gateway to Cutting-Edge Cancer Treatments

Advanced Cancer Treatments in China and Asia

We don't provide treatment, we open doors to access elite oncology centers in China and Asia, specializing in CAR-T, NK cells, TIL, and Gamma Delta T-cell therapies — backed by over 700 active clinical trials.

Est. 2023 | Part of CancerFax International Network |Coordination across 4 continents
  • Accurate initial medical evaluation within 48 hours by oncology experts
  • Access coordination to exclusive public and private centers in China
  • Comprehensive companion and support services in Arabic
  • Full transparency: No fees for coordination services
Medically Reviewed: Information on this site is reviewed by a team of oncology specialists in China. Last review: June 2026.
Meet our medical team →
0+
Active Clinical Trials in China
0+
Partner Oncology Centers
0+
Countries Served
0
Patient Support Languages

You're Not Alone in This Journey

Whatever your treatment stage, we're here to bridge you to the latest medical advances

For Those Seeking Hope

  • Confirm diagnosis with international experts
  • Review your treatment plan from top oncologists
  • Explore advanced treatment options based on your case
Our Goal: Help you understand if advanced treatments are possible for your case.

For Those Seeking Latest Science

  • Candidates for CAR-T cell therapy
  • Immunotherapy options available in Asia
  • Clinical trial matching across continents
Our Goal: Find realistic options for CAR-T and cellular therapy.

For Those Seeking World-Class Care with Dignity

  • Choose the right oncology center
  • Medical visa assistance
  • Travel and accommodation coordination
Our Goal: Simplify your journey to cancer treatment abroad.

Data and Insights

Facts and figures based on the latest studies to help you on your treatment journey

CAR-T Cost by Country

$30K–$500K

China: $30-80K | USA: $375-500K

Treatment Wait Time

2–8 Weeks

China: 2-4 weeks | USA & Europe: 4-8 weeks

Active Clinical Trials

700+

China leads the world in CAR-T and immunotherapy trials

Survival Rate Comparison

2×–3×

Improved survival with cellular therapy vs chemotherapy

Targeted Therapies We Coordinate Access To

Latest cellular immunotherapies backed by advanced clinical research

How We Work

Treatment access coordination in 5 clear steps

1

Medical Records Review

Send medical reports for initial review. Response within 48 hours.

2

Matching the Right Oncology Center

We match your case with appropriate partner oncology centers.

3

Treatment Options Presentation

Receive detailed treatment proposals and transparent costs.

4

Admission and Ethics Approval

Official admission from the oncology center.

5

Treatment and Ongoing Support

Travel coordination, visa assistance, and non-medical support.

Why Choose CancerCareE

Our approach based on trust and science

Fully Transparent Process

Clear communication at every step with no hidden fees.

Global Oncology Center Network

Partnerships with accredited oncology centers in Europe, America, and Asia.

Dedicated Coordination Team

Personal coordinator assisting with all non-medical aspects.

Multi-Language Support

Coordination available in Arabic, English, Turkish, Russian, and Persian.

Cellular Therapy Specialization

Specialized expertise in CAR-T and cellular immunotherapies.

Clear and Transparent Role

We are access coordinators, not a hospital.

Leading Partner Oncology Specialists

Meet our partner medical team specialized in advanced treatments

Dr. Brian Liu, CAR-T and Gene Therapy Specialist in China
Board-Certified Oncologist

Dr. Brian Liu

CAR-T & Gene Therapy Specialist

Specialist in CAR-T treatment for blood cancers and leading gene therapy approaches in China.

View Profile
Dr. Qian Li, Hematology and Stem Cell Transplant Specialist in China
Hematology Specialist

Dr. Qian Li

CAR-T & Stem Cell Transplant

Expert in CAR-T therapy for refractory blood disorders and stem cell transplantation in China.

View Profile
Dr. Yafei Wang, Hematology and Bone Marrow Transplant Specialist in China
Hematology Specialist

Dr. Yafei Wang

Hematology & Bone Marrow Transplant

Leading specialist in multiple myeloma, lymphoma, leukemia, and advanced transplant techniques.

View Profile

Patient Stories

Real stories of patients who accessed advanced cancer treatments

Acute lymphoblastic leukemia patient after successful CAR-T treatment in China

After relapsing with 90% blast cells, CAR-T therapy in China achieved complete remission.

B-Cell Acute Lymphoblastic Leukemia (B-ALL)
✓ Complete Remission Achieved
Neuroblastoma patient who traveled from Russia for treatment in China

Traveled from Russia for neuroblastoma treatment — our comprehensive services made the journey smooth and successful.

Neuroblastoma
✓ Treatment in China — From Russia
Advanced lymphoma patient who received targeted CAR-T therapy in China

Targeted CAR-T therapy in China gave new hope when conventional treatments failed.

Advanced-Stage Lymphoma
✓ Successful CAR-T Treatment

Medical Library

Trusted educational content about advanced cancer treatments

Illustration about failure of traditional cancer treatments

What After Traditional Treatment Failure?

Understanding treatment pathways for patients who have exhausted conventional options.

Read Article
Illustration of CAR-T and cellular therapy basics

CAR-T and Cellular Therapy Basics

Comprehensive patient guide to cellular immunotherapies.

Read Article
Medical tourism guide for international patients in Asia and Europe

Treatment Access Guides: Asia and Europe

Practical information for international patients.

Read Article

Frequently Asked Questions

Common questions about treatment access coordination services

For Hospitals, Physicians & Medical Partners

Are you an oncology center or medical specialist interested in partnering with us?

Learn About Partnership Opportunities